Chengdu Kanghong Pharmaceutical Group Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chengdu Kanghong Pharmaceutical Group Co Ltd with three other
companies in this sector in CHINA :
Haisco Pharmaceutical Group Co Ltd
sales of 3.33 billion Chinese Renmimbi [US$517.25 million]
of which 100%
was Pharmaceutical Industry),
Heilongjiang ZBD Pharmaceutical Co Ltd
(3.27 billion Chinese Renmimbi [US$508.21 million]
Anhui Fengyuan Pharmaceutical
(3.32 billion Chinese Renmimbi [US$515.95 million]
of which 51%
was Medicine Retail Circulation).
During the year ended December of 2020, sales at
Chengdu Kanghong Pharmaceutical Group Co Ltd were 3.30 billion Chinese Renmimbi (US$511.90 million).
a very small
increase of 1.2%
versus 2019, when the company's sales were 3.26 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Chengdu Kanghong Pharmaceutical Group Co Ltd
(and since 2015, sales have increased a total of 59%).
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
34.9% in 2020, from
943,256.44 Chinese Renmimbi to 1.27 million Chinese Renmimbi.